Gene · 7468
Papers2,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic Cancer. | Cancer Res | 2024 | 38831749 | PubTator, text mining | PubMed |
| Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches. | J Med Chem | 2024 | 38748070 | PubTator, text mining | PubMed |
| Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader. | J Med Chem | 2024 | 38687638 | PubTator, text mining | PubMed |
| NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome. | Blood | 2024 | 38598835 | PubTator, text mining | PubMed |
| Anchored-fusion enables targeted fusion search in bulk and single-cell RNA sequencing data. | Cell Rep Methods | 2024 | 38503288 | PubTator, text mining | PubMed |
| Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer. | Cancer Lett | 2024 | 38490329 | PubTator, text mining | PubMed |
| A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer. | Cancer Res | 2024 | 38471099 | PubTator, text mining | PubMed |
| Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs. | Eur J Med Chem | 2024 | 38412693 | PubTator, text mining | PubMed |
| NSD family proteins: Rising stars as therapeutic targets. | Cell Insight | 2024 | 38371593 | PubTator, text mining | PubMed |
| Beyond the tail: the consequence of context in histone post-translational modification and chromatin research. | Biochem J | 2024 | 38353483 | PubTator, text mining | PubMed |
| Clinical details of individuals with Rauch-Steindl syndrome due to NSD2 truncating variants. | Mol Genet Genomic Med | 2024 | 38353053 | PubTator, text mining | PubMed |
| Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis. | Cell Signal | 2024 | 38341124 | PubTator, text mining | PubMed |
| Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues. | Protein Sci | 2024 | 38284488 | PubTator, text mining | PubMed |
| CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research. | Cancers (Basel) | 2024 | 38275900 | PubTator, text mining | PubMed |
| NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions. | Int J Mol Sci | 2024 | 38256018 | PubTator, text mining | PubMed |
| IGH::NSD2 Fusion Gene Transcript as Measurable Residual Disease Marker in Multiple Myeloma. | Cancers (Basel) | 2024 | 38254774 | PubTator, text mining | PubMed |
| Decreased NSD2 impairs stromal cell proliferation in human endometrium via reprogramming H3K36me2. | Reproduction | 2024 | 38236723 | PubTator, text mining | PubMed |
| Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases. | Redox Biol | 2024 | 38232457 | PubTator, text mining | PubMed |
| PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2024 | 38226611 | PubTator, text mining | PubMed |
| Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? | Blood Cancer J | 2024 | 38225228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7468/papers?page=8